Barrett & Company, Inc. Abb Vie Inc. Transaction History
Barrett & Company, Inc.
- $237 Billion
- Q4 2024
A detailed history of Barrett & Company, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Barrett & Company, Inc. holds 2,959 shares of ABBV stock, worth $627,485. This represents 0.22% of its overall portfolio holdings.
Number of Shares
2,959
Previous 2,947
0.41%
Holding current value
$627,485
Previous $582 Million
9.65%
% of portfolio
0.22%
Previous 0.25%
Shares
8 transactions
Others Institutions Holding ABBV
# of Institutions
4,108Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$36.7 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$28.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$16.9 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$11 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.42 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $375B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...